| Lipid Composition for LHP-501 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dimyristoyl-sn-glycero-3-phosphocholine | 10 | 14.75 | 100 |
| Lipid Composition for LHP-502 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dipentadecanoyl-sn-glycero-3-phosphocholine | 10 | 14.16 | 100 |
| Lipid Composition for LHP-503 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dipalmitoyl-sn-glycero-3-phosphocholine | 10 | 13.62 | 100 |
| Lipid Composition for LHP-504 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-diheptadecanoyl-sn-glycero-3-phosphocholine | 10 | 13.12 | 100 |
| Lipid Composition for LHP-505 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-distearoyl-sn-glycero-3-phosphocholine | 10 | 12.66 | 100 |
| Lipid Composition for LHP-506 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dinonadecanoyl-sn-glycero-3-phosphocholine | 10 | 12.22 | 100 |
| Lipid Composition for LHP-507 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-diarachidoyl-sn-glycero-3-phosphocholine | 10 | 11.82 | 100 |
| Lipid Composition for LHP-508 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-diheneicosanoyl-sn-glycero-3-phosphocholine | 10 | 11.44 | 100 |
| Lipid Composition for LHP-509 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dibehenoyl-sn-glycero-3-phosphocholine | 10 | 11.08 | 100 |
| Lipid Composition for LHP-510 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-ditricosanoyl-sn-glycero-3-phosphocholine | 10 | 10.75 | 100 |
| Lipid Composition for LHP-511 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dilignoceroyl-sn-glycero-3-phosphocholine | 10 | 10.43 | 100 |
| Lipid Composition for LHP-512 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine | 10 | 14.16 | 100 |
| Lipid Composition for LHP-513 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1-myristoyl-2-stearoyl-sn-glycero-3-phosphocholine | 10 | 13.62 | 100 |
| Lipid Composition for LHP-514 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1-palmitoyl-2-myristoyl-sn-glycero-3-phosphocholine | 10 | 14.16 | 100 |
| Lipid Composition for LHP-515 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine | 10 | 13.12 | 100 |
| Lipid Composition for LHP-516 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dimyristoyl-sn-glycero-3-phosphocholine | 8.04 | 11.86 | 70 |
| Cholesterol | 1.96 | 5.08 | 30 |
| Total | 10 mg/vial | 16.94 | 100 |
| Lipid Composition for LHP-517 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dipentadecanoyl-sn-glycero-3-phosphocholine | 8.10 | 11.47 | 70 |
| Cholesterol | 1.90 | 4.92 | 30 |
| Total | 10 mg/vial | 16.39 | 100 |
| Lipid Composition for LHP-518 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dipalmitoyl-sn-glycero-3-phosphocholine | 8.16 | 11.12 | 70 |
| Cholesterol | 1.84 | 4.76 | 30 |
| Total | 10 mg/vial | 15.88 | 100 |
| Lipid Composition for LHP-519 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-diheptadecanoyl-sn-glycero-3-phosphocholine | 8.21 | 10.77 | 70 |
| Cholesterol | 1.79 | 4.62 | 30 |
| Total | 10 mg/vial | 15.39 | 100 |
| Lipid Composition for LHP-520 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-distearoyl-sn-glycero-3-phosphocholine | 8.27 | 10.47 | 70 |
| Cholesterol | 1.73 | 4.49 | 30 |
| Total | 10 mg/vial | 14.96 | 100 |
| Lipid Composition for LHP-521 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dinonadecanoyl-sn-glycero-3-phosphocholine | 8.32 | 10.16 | 70 |
| Cholesterol | 1.68 | 4.36 | 30 |
| Total | 10 mg/vial | 14.52 | 100 |
| Lipid Composition for LHP-522 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-diarachidoyl-sn-glycero-3-phosphocholine | 8.36 | 9.88 | 70 |
| Cholesterol | 1.64 | 4.24 | 30 |
| Total | 10 mg/vial | 14.12 | 100 |
| Lipid Composition for LHP-523 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-diheneicosanoyl-sn-glycero-3-phosphocholine | 8.41 | 9.62 | 70 |
| Cholesterol | 1.59 | 4.12 | 30 |
| Total | 10 mg/vial | 13.74 | 100 |
| Lipid Composition for LHP-524 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dibehenoyl-sn-glycero-3-phosphocholine | 8.45 | 9.37 | 70 |
| Cholesterol | 1.55 | 4.01 | 30 |
| Total | 10 mg/vial | 13.38 | 100 |
| Lipid Composition for LHP-525 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-ditricosanoyl-sn-glycero-3-phosphocholine | 8.49 | 9.12 | 70 |
| Cholesterol | 1.51 | 3.91 | 30 |
| Total | 10 mg/vial | 13.03 | 100 |
| Lipid Composition for LHP-526 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dilignoceroyl-sn-glycero-3-phosphocholine | 8.53 | 8.90 | 70 |
| Cholesterol | 1.47 | 3.81 | 30 |
| Total | 10 mg/vial | 12.71 | 100 |
